Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers ( Adaptive PET II)

NCT03403465 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT03403465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03403465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers ( Adaptive PET II)
Lead sponsor
Duke University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 27, 2018
Completion date
April 5, 2028
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anal canal cancer, cancer of the cervix, esophageal cancer, vulvar cancer